New York State Common Retirement Fund
INMB icon

New York State Common Retirement Fund’s INmune Bio INMB Stock Holding History

New York State Common Retirement Fund’s Portfolio INMB Stock Details INMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-500
Closed -$565 – 3253
2026
Q1 		$565 Hold
500
– – ﹤0.01% 3129
2025
Q4 		$780 Hold
500
– – ﹤0.01% 3174
2025
Q3 		$1.03K Hold
500
– – ﹤0.01% 3180
2025
Q2 		$1.16K Hold
500
– – ﹤0.01% 3195
2025
Q1 		$3.9K Hold
500
– – ﹤0.01% 3137
2024
Q4 		$2.33K Hold
500
– – ﹤0.01% 3159
2024
Q3 		$2.69K Sell
500
-11,100
-96% -$78.9K ﹤0.01% 3160
2024
Q2 		$102K Buy
+11,600
New +$114K ﹤0.01% 2794

Other funds holding INMB

CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return
AHL
Abel Hall LLC Baton Rouge, Louisiana $579M AUM 54.21% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
LSA
Leonteq Securities AG Zurich, Switzerland $2.91B AUM 56.5% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

New York State Common Retirement Fund's INMB Position: Q2 2026 in Review

New York State Common Retirement Fund sold out of INmune Bio (INMB) in Q2 2026, closing a stake of 500 shares — an estimated $565 sold.

New York State Common Retirement Fund first reported a position in INMB in Q2 2024 and held it in 8 quarters. The position peaked at $102K in Q2 2024. 16 funds tracked by Wall St. Rank hold INMB as of Q2 2026.

  • New York State Common Retirement Fund reported no remaining INmune Bio position as of Q2 2026 after selling out during the quarter.
  • New York State Common Retirement Fund sold 500 INmune Bio shares in Q2 2026, an estimated $565.
  • New York State Common Retirement Fund first reported a position in INmune Bio in Q2 2024 and held it in 8 quarters.
  • New York State Common Retirement Fund's INmune Bio position peaked at $102K in Q2 2024.
  • 16 funds tracked by Wall St. Rank held INmune Bio as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.